Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN118724934B reveals solvent-free mechanochemical synthesis for alpha-haloalkylboron esters, offering cost reduction and scalable supply chain solutions for pharma intermediates.
Patent CN119504765A reveals a green Pd-catalyzed route for Alline alkaloids. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Patent CN109369504B details a novel Pd-catalyzed method for sulfur-containing 3-methyleneisoindolin-1-one derivatives, offering streamlined synthesis for reliable pharmaceutical intermediate suppliers.
Novel palladium-catalyzed cyanation using potassium ferrocyanide ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel one-step synthesis improves yield by 15-30%. Offers cost-effective scalable production for global supply chains.
Patent CN117659009A reveals a chiral induction method for moxifloxacin side chain. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105859648B reveals high-yield Peramivir intermediate synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Novel Cu-catalyzed click chemistry route for 1,2,3-triazole cinnamic acids. Offers mild conditions and high selectivity for scalable pharmaceutical intermediate manufacturing.
Patent CN113929702A details a high-yield Everolimus synthesis using ethylene carbonate, offering significant cost reduction and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN103467552A reveals a metal-free route for 8-cyclohexyl-2-fluoro-vidarabine. Enhanced purity and scalable manufacturing for anti-leukemia drug development.
Patent CN111253254A details a green CuCl2-catalyzed dichlorination method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Advanced synthesis of Barnidipine Hydrochloride via chiral resolution. High purity, scalable route for API manufacturing. Cost-effective solution for hypertension drugs.
Patent CN111253254B details a mild visible light method for dichloride synthesis using CuCl2. This offers cost reduction in fine chemical manufacturing and reliable supply.
Novel Pd-catalyzed thiocarbonylation route for indolinone thioesters. Enhanced purity, scalable process, cost-effective sulfonyl chloride sulfur source.
Patent CN105418460B reveals safer Pimavanserin intermediate synthesis avoiding phosgene. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN119894868B offers high-purity JAK inhibitor intermediate synthesis with reduced costs and scalable processes for reliable pharmaceutical intermediates supply chains.
Patent CN108409764A reveals nickel synergistic BODIPY catalysts. Enables cost-effective C-X bond formation. Reliable supply for pharma intermediates.
Novel one-step carbonylation method offers mild conditions and high yields for 3,4-substituted coumarins, ensuring reliable supply chain stability.
Novel synthesis of Roxadustat via Bischler-Napieralski cyclization offers high purity and cost efficiency for pharmaceutical intermediate manufacturing.